Latest News Archive
Please select Category, Year, and then Month to display items
17 October 2024
|
Story Precious Shamase
|
Photo Supplied
Sibahle Mabaso during her BA (Hons) Drama and Theatre Arts (2022) graduation, which she passed cum laude.
Sibahle Mabaso, a talented and driven individual, has been making waves at the University of the Free State (UFS). As a runner-up in the prestigious Siyaphumelela ATD DREAM Scholar programme, Mabaso's dedication and achievements have not gone unnoticed.
A multi-faceted student, Mabaso excelled in both her academic pursuits and extracurricular activities. A graduate of the UFS Drama and Theatre Arts programme, Mabaso's academic pursuits have been as diverse as her interests. She has a BA in Drama and Theatre Arts (2019-2021), a BA Honours in Drama and Theatre Arts (2022), and she is currently pursuing a Master of Arts with specialisation in Gender Studies. Her passion for the arts is evident in her work as a playwright, director, and educator. Mabaso is currently an Assistant Researcher in Transition, Development and Success within the Centre for Teaching and Learning.
Mabaso's journey to academic success has been marked by resilience and perseverance. Despite facing challenges, she has overcome obstacles through hard work, determination, and the support of mentors.
Beyond her academic achievements, Mabaso is committed to giving back to her community. She recently founded a creative enterprise called Wild Geese PTY LTD, which aims to provide opportunities for young creatives. Through her work, Mabaso hopes to inspire and mentor others, sharing her experiences and knowledge to help them reach their full potential.
As Mabaso continues her academic journey and pursues her career goals, her dedication and passion for both her studies and community engagement are sure to inspire others. Her achievements serve as a testament to the power of hard work, resilience, and a commitment to making a positive impact. Looking ahead, Mabaso hopes to continue her academic pursuits and pursue a career in higher education. She is also passionate about giving back to her community and mentoring young people. With her talent, dedication, and unwavering spirit, there is no doubt that Sibahle Mabaso will continue to achieve great things.
DNA sequencer launched at the UFS
2013-11-25
 |
| Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them. |
The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.
The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.
The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.
The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.
The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.
“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.
Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”